FDA Clearance Tracker · P010022-S001
COSEAL SURGICAL SEALANT (PREMIXED)
Last checked: Nov 20, 2026Latest source record: Feb 4, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Feb 4, 2003
Approved
Time to decision
179 days
Received Aug 9, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010022-S001
- Device name
- COSEAL SURGICAL SEALANT (PREMIXED)
- Applicant location
- Gainesville, FL
- Received
- Aug 9, 2002
- Decided
- Feb 4, 2003
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P010022
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR: 1) CHANGE IN PACKAGING OF THE POLYMER RESINS TO A PRE-MIXED CONFIGURATION; 2) CHANGE IN BUFFER A TO A DILUTE HYDROGEN CHLORIDE SOLUTION WITH A PH OF 2.2; 3) CHANGE IN STERILIZATION TO GAMMA RADIATION; AND 4) CHANGE TO ROOM TEMPERATURE STORAGE.
Source documents
Other decisions for Angiotech Medical Device Technologies
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.